TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ)

Historical Holders from Q4 2024 to Q2 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
RNAZ on Nasdaq
Shares outstanding
700,000
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
SABBY MANAGEMENT, LLC 9.9% $26,431 69,555 SABBY MANAGEMENT, LLC 31 Dec 2024
Tracy Thomas Joseph 5% $13,300 35,000 Thomas Joseph Tracy 07 Mar 2025
Anson Funds Management LP 0.1% -98% $9,494 -$30,224 27,125 -76% Anson Funds Management LP 30 Jun 2025

Institutional Holders of TRANSCODE THERAPEUTICS, INC. - Common Stock, $0.0001 par value (RNAZ) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q2 0 $0 -$1,053,827 0
2025 Q1 2,128,495 $1,053,827 +$1,048,922 49.5% 15
2024 Q4 9,910 $33,396 +$33,396 336.92% 4